O
Oruka Therapeutics, Inc. (ORKA)
NGM – Real vaqt narxi. Valyuta: USD
64.65
-1.03 (-1.57%)
Yopilishda: May 12, 2026, 4:00 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NGM – Real vaqt narxi. Valyuta: USD
64.65
-1.03 (-1.57%)
Yopilishda: May 12, 2026, 4:00 PM EDT
Oruka Therapeutics, Inc., klinik bosqichdagi biofarmatsevtika kompaniyasi, psoriaz (PsO) va boshqa yallig'lanish va immunologik (I&I) ko'rsatmalari uchun yangi monoklonal antitelalardan iborat terapevtik vositalarni ishlab chiqishga qaratilgan. Uning asosiy mahsulotlari orasida psoriazni (PsO) davolash uchun 2a fazali sinovda bo'lgan va interleikin-23 ning p19 subbirligiga qaratilgan ORKA-001; va psoriazni (PsO), psoriatik artritni va boshqa sharoitlarni davolash uchun 2-fazali sinovda bo'lgan va interleikin-17A va interleikin-17F ga qaratilgan ORKA-002 mavjud. Kompaniya, shuningdek, ko'rsatilmagan yo'nalishga qaratilgan ORKA-003; va ORKA-002 va ORKA-001 ning ketma-ket kombinatsiyalangan rejimi bo'lgan ORKA-021 ni ishlab chiqadi. Oruka Therapeutics, Inc. Kaliforniyaning Menlo Park shahrida joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Joana Goncalves M.D. | Chief Medical Officer |
| Dr. Lawrence Otto Klein Ph.D. | President, CEO & Director |
| Dr. Rajiv Panwar | Senior VP and Head of Chemistry, Manufacturing & Controls |
| Mr. Alan Lada | VP of IR & Capital Markets |
| Mr. Arjun Agarwal CPA | Senior VP of Finance & Treasurer |
| Mr. Christopher Finch | Senior VP and Head of Business Development & Strategy |
| Mr. Paul T. Quinlan | General Counsel & Secretary |
| Ms. Laura Sandler | Chief Operating Officer |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-04-30 | 8-K | ea0288461-8k_oruka.htm |
| 2026-04-27 | 8-K | ea0287782-8k_oruka.htm |
| 2026-04-17 | DEFA14A | ea0286400-04.htm |
| 2026-04-17 | DEF 14A | ea0286400-01.htm |
| 2026-04-08 | CORRESP | filename1.htm |
| 2026-04-02 | S-3 | ea0284246-s3_oruka.htm |
| 2026-03-12 | 10-K | ea0273300-10k_oruka.htm |
| 2025-12-11 | 8-K | ea0268925-8k_oruka.htm |
| 2025-11-12 | 10-Q | ea0262412-10q_oruka.htm |
| 2025-10-14 | S-3/A | ea026112601-s3a1_oruka.htm |